Suscripción a Biblioteca: Guest

A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey

Volumen 6, Edición 1-2, 2015, pp. 57-65
DOI: 10.1615/ForumImmunDisTher.2016014169
Get accessGet access

SINOPSIS

Foundational cellular immunology research of the 1960s and 1970s, together with the advent of monoclonal antibodies and flow cytometry, provided the knowledge base and the technological capability that enabled the elucidation of the role of CD4 T cells in HIV infection. Research identifying the sources and magnitude of variation in CD4 measurements, standardized reagents and protocols, and the development of clinical flow cytometers all contributed to the feasibility of widespread CD4 testing. Cohort studies and clinical trials provided the context for establishing the utility of CD4 for prognosis in HIV-infected persons, initial assessment of in vivo antiretroviral drug activity, and as a surrogate marker for clinical outcome in antiretroviral therapeutic trials. Even with sensitive HIV viral load measurement, CD4 cell counting is still utilized in determining antiretroviral therapy eligibility and time to initiate therapy. New point of care technologies are helping both to lower the cost of CD4 testing and enable its use in HIV test and treat programs around the world.

CITADO POR
  1. Hassan Joanne, Wangai Laura, Borus Peter, Khayeka–Wandabwa Christopher, Karani Lucy Wanja, Kithinji Mercy, Kiptoo Michael, Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children, BMC Research Notes, 10, 1, 2017. Crossref

  2. Mishra Shravan Kumar, Shrestha Lilee, Pandit Roshan, Khadka Sundar, Shrestha Bimal, Dhital Subhash, Sharma Saroj, Sharma Mukunda, Mahato Raj Kumar, Shakya Geeta, Das Manandhar Krishna, Establishment of reference range of CD4 T-lymphocyte in healthy Nepalese adults, BMC Research Notes, 13, 1, 2020. Crossref

  3. Goyal Ramesh K., Aggarwal Geeta, Biomarker-Based Drug Discovery with Reverse Translational Approach, in Biomedical Translational Research, 2022. Crossref

  4. Shu Wen, Du Fei, Bai Jin-Song, Yin Ling-Yun, Duan Kai-Wen, Li Cheng-Wen, A Real-world Evidence-based Management of HIV by Differential Duration HAART Treatment and its Association with Incidence of Oral Lesions, Current HIV Research, 20, 1, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain